Rogaine exclusivity preliminary injunction hearing set for April 25.
This article was originally published in The Tan Sheet
Executive Summary
OTC MINOXIDIL ANDA APPROVALS SUSPENDED BY FDA under a temporary restraining order issued by Michigan federal court Judge Robert Holmes Bell on April 15. The order effectively bars generic manufacturers Alpharma, Teva and Bausch & Lomb -- all of which have received ANDA approvals for minoxidil 2% hair regrowth treatment for men -- from marketing private label versions of Pharmacia & Upjohn's OTC Rogaine until a further ruling.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning